RUNX1 Antikörper (AA 200-233)
Kurzübersicht für RUNX1 Antikörper (AA 200-233) (ABIN2616047)
Target
Alle RUNX1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 200-233
-
Spezifität
- Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.
-
Aufreinigung
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence in the middle region of human RUNX1(200-233aa ELEQLRRTAMRVSPHHPAPTPNPRASLNHSTAFN), identical to the related mouse and rat sequences.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))
-
Andere Bezeichnung
- AML1 / RUNX1
-
Hintergrund
-
Name/Gene ID: RUNX1
Synonyms: RUNX1, AMLCR1, Aml1 oncogene, AML1, AML1-EVI-1, CBF-alpha-2, CBFA2, Acute myeloid leukemia 1, EVI-1, PEBP2A2, PEA2-alpha B, AML1-EVI-1 fusion protein, Oncogene AML-1, PEBP2-alpha B, PEBP2aB -
Gen-ID
- 861
Target
-